AMSBIO has published an interview with researchers at Yamaguchi University Graduate School of Medicine, Department of Gastroenterology and Hepatology, Japan, that covers their groundbreaking work to develop cell regeneration therapies for liver cirrhosis.
News
AT247, a promising candidate in the pursuit for next generation insulins to improve glycemic control
Cambridge, UK, 16 December 2020: Arecor Limited (“Arecor” or “the Company”), the biopharmaceutical company advancing today’s therapies to enable healthier lives, today announces that Diabetes Care has published data for the Phase I clinical trial of AT247, its ultra-rapid acting insulin product candidate.
CAMBRIDGE, UK (Dec 15th, 2020) – Nuclera, the UK-based biotech company developing desktop gene and protein printing technologies, announces that it has been awarded a Knowledge Transfer Partnership (KTP) grant in support of its work with researchers at the University of Southampton.
Development of a rapid acting concentrated insulin for advanced delivery systems and enabling fewer injections for high dose diabetics
Cambridge, UK., 14 December 2020: Arecor Limited (“Arecor” or “the Company”), the biopharmaceutical company advancing today’s therapies to enable healthier lives announces dosing of the first patient in a Phase I clinical trial for its second clinical stage product, an ultra-concentrated rapid acting insulin, AT278.
We have just published a "Quick guide to implementing a Health and Safety management system". The guide is featured in the London Biosciences Innovation Centre (LBIC) newsletter. Read on page 4 for tips about how to achieve this: https://bit.ly/3oqhipQ. We also providing clients with biosafety support. For health, safety and biosafety support contact Bishop Simon Ltd at info@bishopsimon.co.uk
• State-of-the-art site will enable rapid delivery of engineered cell lines
• Powering ready-to-use edited cell-line portfolio expansion
• Enable comprehensive customization for research, diagnostic and therapeutic development
Cambridge, UK, 27th November 2020 / Sciad Newswire / One Nucleus reveals the finalists of its annual BioNewsRound Award, recognising life science companies who have anno
BioIVT is contributing to four healthcare organizations this year, focusing on cancer, liver diseases, Alzheimer’s disease, and global health equity
Westbury, NY – Dec. 1, 2020 – BioIVT, a leading provider of research models and services for drug and diagnostic development, today announced that it is making several charitable donations in December to honor its clients' commitment to medical research.
Cambridge, United Kingdom – 1 December 2020 - Congenica, the digital health company enabling rapid and accurate analysis of complex genomic data to transform people’s lives, is pleased to announce the appointment of Dr. Muthu Meyyappan as Chief Commercial Officer (CCO), effective immediately. Muthu will lead all aspects of Congenica’s sales and marketing and will be based in Boston, MA.
Global executive search and interim management specialist, Horton International UK, is delighted to announce the appointment of Emma Whittle as Partner within its Global Healthcare arm.
Emma brings to the team over 20 years’ experience within search and talent acquisition, built across a range of industries and with significant emphasis on hiring for the life sciences sectors, including technology digitalisation, medical technology and diagnostics.